These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 1841493
1. [The fate of children after discontinuation of treatment for acute lymphoblastic leukemia]. Derulska D, Rokicka-Milewska R, Jackowska T, Armata J, Balwierz W, Bogusławska-Jaworska J, Chybicka A, Cyklis R, Darmal B, Jakowicka M. Acta Haematol Pol; 1991; 22(2):223-32. PubMed ID: 1841493 [Abstract] [Full Text] [Related]
5. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. Skoczeń S, Balwierz W, Moryl-Bujakowska A, Pawińska K, Luszczyńska A, Balcerska A, Płoszyńska A, Chybicka A, Dobaczewski G, Juszczak K, Wachowiak J, Derwich K, Kowalczyk J, Wiśniewska-Slusarz H, Matysiak M, Krauze A, Pawelec K, Sońta-Jakimczyk D, Tomaszewska R, Wysocki M, Styczyńskii J, Swiatkiewicz V, Polish Pediatric Leukemia/Lymphoma Study Group. Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892 [Abstract] [Full Text] [Related]
6. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546 [Abstract] [Full Text] [Related]
7. [Prognostic value of the reaction to steroids in the treatment of acute lymphoblastic leukemia in children]. Urasiński T, Peregud-Pogorzelski J, Bartoszewicz L. Pol Tyg Lek; 1989; 47(16-17):360-2. PubMed ID: 1437754 [Abstract] [Full Text] [Related]
8. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. Desai SJ, Barr RD, Andrew M, deVeber LL, Pai MK. CMAJ; 1989 Oct 01; 141(7):693-7. PubMed ID: 2790605 [Abstract] [Full Text] [Related]
10. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan. Matsuzaki A, Ishii E, Okamura J, Eguchi H, Yoshida N, Yanai F, Inoue T, Miyake K, Ishihara T, Tsuboi C. Med Pediatr Oncol; 1996 Jan 01; 26(1):10-9. PubMed ID: 7494507 [Abstract] [Full Text] [Related]
12. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ. J Clin Oncol; 2008 Apr 10; 26(11):1843-9. PubMed ID: 18398150 [Abstract] [Full Text] [Related]
13. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E, Eguchi H, Matsuzaki A, Koga H, Yanai F, Kuroda H, Kawakami K, Ayukawa H, Akiyoshi K, Kamizono J, Tamai Y, Kinukawa N, Okamura J. Med Pediatr Oncol; 2001 Jul 10; 37(1):10-9. PubMed ID: 11466717 [Abstract] [Full Text] [Related]